This inventor holds 3 USPTO granted patents. Top assignee: Washington State University. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2015
Title: Brent J Yamamoto: Innovator in Medical Research
Introduction
Brent J Yamamoto is a notable inventor based in Pullman, WA (US). He has made significant contributions to the field of medical research, particularly in understanding the c-Met receptor and its implications in various health conditions. With a total of 3 patents, his work focuses on innovative methods for diagnosing and treating diseases associated with c-Met dysregulation.
Latest Patents
One of his latest patents is titled "C-Met receptor regulation by angiotensin IV (AT4) receptor ligands." This patent outlines compositions and methods for using angiotensin-like factors to diagnose, prevent, and treat conditions such as cancer, obesity, and neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. The research highlights the role of the c-Met receptor in processes like cell motility, angiogenesis, and cancer metastasis, providing a foundation for future therapeutic strategies.
Career Highlights
Brent J Yamamoto is affiliated with Washington State University, where he continues to advance his research in medical innovations. His work has garnered attention for its potential impact on treating serious health conditions, making him a valuable asset in the field of medical research.
Collaborations
He collaborates with esteemed colleagues such as Patrick D Elias and Joseph W Harding, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Brent J Yamamoto's contributions to medical research through his patents and collaborations highlight his commitment to advancing healthcare solutions. His innovative approaches to understanding c-Met dysregulation pave the way for new treatments and improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
